Eosinophil surface receptor EMR1: a novel therapeutic target for eosinophilic disorders

BACKGROUND: Although several novel agents are currently in clinical trials for eosinophilic disorders, none has demonstrated efficacy in reducing blood and tissue eosinophilia in all subjects. Additional approaches are clearly needed. OBJECTIVE: To explore the potential of the human eosinophil surfa...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Legrand, Fanny, Tomasevic, Nenad, Simakova, Olga, Lee, Chyi-Chia Richard, Wang, Zengfang, Raffeld, Mark, Makiya, Michelle A., Palath, Varghese, Leung, John, Baer, Mark, Yarranton, Geoffrey, Maric, Irina, Bebbington, Christopher, Klion, Amy D.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4113341/
https://ncbi.nlm.nih.gov/pubmed/24530099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2013.11.041
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires